Hospital visits among women with skeletal-related events secondary to breast cancer and bone metastases: A nationwide population-based cohort study in Denmark

Clinical Epidemiology

Volumn 5, Issue 1, 2013, Pages 97-103

  Svendsen, Marie Louise ^a   Gammelager, Henrik ^a   Sværke, Claus ^a   Yong, Mellissa ^b   Chia, Victoria M ^b   Christiansen, Christian F ^a   Fryzek, Jon P ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AMGEN INC   (United States)

Author keywords

Bone metastases; Breast neoplasms; Hospital services; Skeletal related events; Utilization

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; EMERGENCY CARE; FEMALE; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PATHOLOGIC FRACTURE; SPINAL CORD COMPRESSION;

EID: 84875657706     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S42325     Document Type: Article

References (26)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747-1757.
3. Danish National Board of Health. Cancer registry 2010. Copenhagen, Denmark: Danish National Board of Health; 2011. Available from: http://www.ssi.dk/Sundhedsdataogit/Registre/Cancerregisteret.aspx. Accessed February 18, 2013.
4. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103(2):117-128.
5. Jensen AØ, Jacobsen JB, Nørgaard M, Yong M, Fryzek JP, Sørensen HT. Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark. BMC Cancer. 2011;11:29.
6. Louwman WJ, Voogd AC, van Dijck JA, etal. On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control. 2008;19(1):97-106.
7. Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987;55(1):61-66.
8. van den Hurk CJ, Eckel R, van de Poll-Franse LV, etal. Unfavourable pattern of metastases in M0 breast cancer patients during 1978-2008: a population-based analysis of the Munich Cancer Registry. Breast Cancer Res Treat. 2011;128(3):795-805.
9. Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27(3):165-176.
10. Lidgren M, Wilking N, Jönsson B, Rehnberg C. Resource use and costs associated with different states of breast cancer. Int J Technol Assess Health Care. 2007;23(2):223-231.
11. Schulman KL, Kohles J. Economic burden of metastatic bone disease in the US. Cancer. 2007;109(11):2334-2342.
12. Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100(12):888-897.
13. Foster TS, Miller JD, Boye ME, Blieden MB, Gidwani R, Russell MW. The economic burden of metastatic breast cancer: a systematic review of literature from developed countries. Cancer Treat Rev. 2011;37(6):405-415.
14. Delea T, McKiernan J, Brandman J, etal. Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol. 2006;4(7):341-347.
15. Pockett RD, Castellano D, McEwan P, Oglesby A, Barber BL, Chung K. The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain. Eur J Cancer Care (Engl). 2010;19(6): 755-760.
16. Félix J, Andreozzi V, Soares M, etal. Hospital resource utilization and treatment cost of skeletal-related events in patients with metastatic breast or prostate cancer: estimation for the Portuguese National Health System. Value Health. 2011;14(4):499-505.
17. Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287(5462):2398-2399.
18. Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39(Suppl 7):22-25.
19. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(Suppl 7):42-45.
20. Ording AG, Nielsson MS, Frøslev T, Friis S, Garne JP, Søgaard M. Completeness of breast cancer staging in the Danish Cancer Registry, 2004-2009. Clin Epidemiol. 2012;4 Suppl 2:11-16.
21. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(Suppl 7):30-33.
22. Barlev A, Song X, Ivanov B, Setty V, Chung K. Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer. J Manag Care Pharm. 2010;16(9):693-702.
23. Dinan MA, Curtis LH, Hammill BG, etal. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA. 2010;303(16):1625-1631.
24. Hansen RP, Vedsted P, Sokolowski I, Søndergaard J, Olesen F. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 2011;11:284.
25. Jensen AØ, Nørgaard M, Yong M, Fryzek JP, Sørensen HT. Validity of the recorded International Classification of Diseases, 10th edition diagnoses codes of bone metastases and skeletal-related events in breast and prostate cancer patients in the Danish National Registry of Patients. Clin Epidemiol. 2009;1:101-108.
26. Kiderlen M, Bastiaannet E, Walsh PM, etal. Surgical treatment of early stage breast cancer in elderly: an international comparison. Breast Cancer Res Treat. 2012;132(2):675-682.